AdvaMed Privacy Comments Will Seek Clarity On PHI Disclosure Procedure
This article was originally published in The Gray Sheet
Executive SummaryHHS should clarify whether or not protected health information can be released to foreign governments without the permission of FDA under HIPAA privacy guidelines, AdvaMed says
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.